Hydroxyurea (HU), a drug effective in the treatment of sickle cell disease, is thought to indirectly promote fetal hemoglobin (Hb F) production by perturbing the maturation of erythroid precursors. The molecular mechanisms involved in HU-mediated regulation of -globin expression are currently unclear. We identified an HU-induced small GTPbinding protein, secretion-associated and ras-related (SAR), in adult erythroid cells using differential display. Stable SAR expression in K562 cells increased -globin mRNA expression and resulted in macrocytosis and cells that appeared immature. SAR-mediated induction of -globin also inhibited K562 cell growth by causing arrest in G1/S, apoptosis, and delay of maturation, cellular changes consistent with the previously known effects of HU on erythroid cells. SAR also enhanced both -and -globin transcription in primary bone marrow CD34+ cells, with a greater effect on -globin than on -globin.
Introduction
Hydroxyurea (HU), a ribonucleotide reductase inhibitor and an S-phase-specific cytotoxic agent, has been successfully used in the clinic to treat sickle cell disease because it augments the production of fetal hemoglobin (Hb F). 1, 2 In a multicenter study (MSH), HU treatment dramatically reduced the frequency of hospitalization due to the incidence of pain, acute chest syndrome, and the blood transfusion requirements in patients with sickle cell disease. 2 After two years of HU treatment, Hb F levels increased from 5% of total Hb to 9% in the majority of patients. 2 Similarly, as Hb F levels became elevated after HU treatment, the rate and extent of sickle hemoglobin (Hb S) polymerization appeared to be reduced. 1 A nine-year follow-up of 233 patients in the original MSH cohort indicated, among other findings, that taking HU was associated with a 40 percent reduction in mortality. 3 Several mechanisms have been proposed to account for the induction of Hb F by HU.
Because HU directly kills late erythroid progenitor cells and triggers rapid erythroid regeneration, 4 HU has been assumed to promote Hb F production by perturbing the maturation of erythroid precursors. Accelerated erythropoiesis increases the chance of premature lineage commitment and the induction of F-cell formation. 5 HU also increases GATA expression, HU also induces expression of genes related to the cell cycle and apoptosis; the actions of HU depend upon its concentration. 7 Induction of peroxidation by HU can generate nitric oxide (NO), 9,10 a known inducer of soluble guanylate cyclase (sGC), which, in turn, can modulate the expression of -globin. 11 However, the molecular mechanisms by which HU regulates -globin gene expression need to be further elucidated. To elucidate the molecular mechanisms underlying the HU-induced elevation of Hb F and to explore new signal transduction pathways related to HU-mediated hemoglobin gene expression, we used mRNA differential display to identify HU inducible gene(s) in human adult erythroid cells. Here, we identify a new small GTPbinding protein, secretion-associated and ras-related (SAR), as a specific HU-inducible gene.
The small GTP-binding protein superfamily comprises more than 100 members in eukaryocytes. 12, 13 Members of the SAR/ADP ribosylation factor (Arf) family are GTPases [14] [15] [16] active in protein trafficking and maturation. 17 SAR itself functions in cargo selection and export of proteins from the endoplasmic reticulum to the Golgi via the cytosolic coat protein complex II (COPII) secretory pathway. It has been reported that several Ras superfamily members participate in hematopoietic cell proliferation and differentiation processes involving endo-and exocytosis or cell adhesion. [18] [19] [20] [21] However, it is unknown whether SAR participates in hemoglobin gene regulation, and which signal transduction pathway SAR uses. Here, we demonstrate that HU-induced SAR plays a pivotal role in -globin gene induction by causing cell apoptosis and G1/S-phase arrest through the reduction of PI3 kinase and ERK phosphorylation and increased p21 and
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Methods

Cell cultures
Two-phase liquid cultures of human adult erythroid cells (HAECs) were prepared from the peripheral blood of healthy donors. Mononuclear cells were isolated by centrifugation over Ficoll-Hypaque (1.077 g/mL, Organon Teknika Co, Durham, North Carolina), washed twice with Dulbecco's phosphate-buffered saline (PBS), and cultured according to a previously published two-phase liquid culture protocol. 22 Cells were treated with 100
µM HU on days 7 and 8, and RNA was collected on day 10 of phase II culture for differential display. K562 cells grew in RPMI 1640 medium supplemented with 10%
FBS plus 4 mM glutamine, 10 U/ml penicillin, and 10 µg/ml streptomycin. Growth curves were performed by seeding cells at a density of 2.5 x10 4 cells/ml, then counting them every 24 h for four days. The morphology of K562 cells was observed after hematoxylin & eosin staining. Enriched primary bone marrow AC133+ cells and CD34+ cells were purchased from Poietic Technologies (Gaithersburg, MD) and cultured according to a previously described protocol.
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Molecular cloning of the SAR gene using differential display
Differential display was performed using an RNA Image Kit (GeneHunter, Nashville, TN). We used a MessageClean DNase I kit (GeneHunter) to eliminate chromosomal 
SAR protein expression in vitro
A full-length SAR cDNA was cloned into the pGEM-T Easy vector (Promega, Madison, WI), then transcribed and translated into an 35 S-labeled peptide using a TNT Quick T7-coupled transcription/translation system (Promega Madison, WI) with [ 35 S]-methionine (15 mCi/ml, Amersham Pharmacia Biotech, Piscataway, NJ). The translation product was subjected to electrophoresis in 4%-12% Bis-Tris gels. The gels were exposed to film to determine the size of the translated product by comparison to known protein standards.
Northern and Western blotting
A SAR cDNA probe was hybridized to Multiple Tissue Northern (MTN™) Blots (Clontech, CA) according to the manufacturer's protocol. Membranes were stripped between probes by incubating the blots in sterile 0.5% SDS solution at 95°C for 10 min.
The Human Cell Cycle filter membrane containing various human cDNAs sequences was 
Powerblot screen
Proteins were separated on 4-15% gradient SDS-polyacrylamide gel and transferred onto Immobilon-P membrane (Millipore, Bedford, MA). After transfer, the membrane was dried and re-wet in methanol, then blocked for one hour with blocking buffer (LI-COR).
Next, the membrane was clamped with a Western blotting manifold that isolated 41 channels across the membrane. In each channel, a complex antibody cocktail was added and allowed to hybridize for one hour at 37ºC. The blot was washed and hybridized for 30 minutes at 37ºC with secondary goat anti-mouse conjugated to Alexa680 fluorescent
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Transfection and gene expression of SAR in K562 cells
We cloned the SAR cDNA into pEF6/V5-His-TOPO (Invitrogen, CA) and stably transfected it into K562 cells by electroporation (Amaxa Biosystems, Cologne, Germany). Stable SAR-expressing clones were selected by culturing the cells in 6 µg/ml blasticidin for two weeks. An antibody directed against the His-tag was used to identify high and low levels of SAR by Western blotting; expression was confirmed by Northern blotting and RT-PCR.
Retrovirus generation and gene transduction in CD34+ hematopoietic stem cells
The SAR coding region with a green fluorescent protein (GFP) tag at the 3' end or GFP alone was subcloned into the pMSCV retroviral expression vector (Clontech, CA). The retroviruses were packaged into PT67 packaging cells. The viral titers were determined and high-titer viral clones were selected. For SAR transduction in CD34+ hematopoietic stem cells, 2 ×10 6 viral particles were preloaded onto a RetroNectin-coated plate (Takara, JP) and incubated at 37 o C for 5 h. Just prior to infection, the viral supernatant was discarded and the plate was washed with PBS; 1x10 5 CD34+ cells were then added to the preloaded viral plate with growth medium, and the plate was incubated at 37 o C. This
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Cell cycle and apoptosis analysis
Cells were counted and centrifuged at 1000 rpm for 5 minutes. The cell pellets were resuspended at a density of 0.5-1.0 x 10 6 cells/ml; 400 µl Quickstain solution (FAST Systems, Inc., Gaithersburg, MD) was then added to each sample, and the samples were 
Statistical analysis
The statistical analysis of the results were obtained using the Student's t test for significance of the difference of individual pairs and the Pearson of correlation coefficient for the closeness of linear relationship.
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Results
Molecular cloning, SAR protein production, and localization in erythroid cells
In vivo studies have shown that continuous infusion of 20 mg/kg HU into patients maintains a serum concentration of HU at 100 µM. 26 In order to obtain an exposure regimen for the differential display study that closely resembled the in vivo pharmacokinetics of HU treatment in patients, HAECs were treated with 100 µM HU on day 7 and day 8, and RNA was collected on day 10. A reverse dot blot was used to confirm differential expression, and one particular transcript was identified that was significantly induced in response to HU treatment. This gene had 92% similarity to the mouse small GTP-binding protein SAR1 by sequence analysis. We then obtained the full- 
SAR-induced -globin gene expression in K562 cells
To determine whether and how SAR regulates -globin gene expression in human erythroid cells, we stably transfected SAR into K562 cells and then analyzed multiple
SAR-expressing and vector-transfected clones. Northern blotting revealed significantly
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From higher -globin mRNA levels in SAR-transfected cells than in vector-transfected cells (Table 1) . To better clarify the correlation between SAR and -globin expression, we divided the SAR-expressing cells into two groups: clones with high -globin gene expression (>2 fold induction) and clones with lower -globin gene expression (<2 fold induction). As shown in Table 1 , both groups had significant induction of -globin mRNA as compared with the vector control (p<0.001), ranging from a 1.5-fold to a 4.3-fold increase in -globin mRNA levels. On average, SAR-expressing clones had 3.5-fold higher levels of -globin mRNA than vector controls. Coexistence of SAR mRNA and high levels of -globin mRNA in K562 cells indicate that HU-induced SAR may be involved in -globin mRNA induction in erythroid cell development.
To investigate whether SAR is a common or specific inducer for the -globin gene, we Second, when parental K562 cells were treated with various hemoglobin gene inducers (hydroxyurea, butyrate, and 5-azacytidine) for 48 h, a Northern blot indicated that all three inducers upregulated -globin mRNA, from 2.5-fold for butyrate to 3.0-fold for hydroxyurea. In the same experiment, SAR mRNA increased in parallel with the -globin mRNA, from 1.5-fold after butyrate treatment to 2.1-fold after hydroxyurea (Figure 2b and 2c). Third, the expression of SAR and -globin mRNA in cultured primary bone marrow AC133 + cells was determined by RT-PCR at different time points. In the presence of EPO, both SAR and -globin mRNA began to be expressed at day 10,
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From reached a peak at day 21, and declined to baseline at day 28, reflecting a similar time course and pattern of gene expression (Figure 2d ). These data further indicate that there is a close temporal relation between SAR and -globin mRNA expression in primary bone marrow cells, and strongly suggest that the SAR and -globin genes coexist in cells of this erythroid lineage.
SAR-induced hemoglobin gene expression in CD34+ hematopoietic stem cells
We next investigated the effects of SAR using primary bone marrow stem cells. A SAR-GFP fusion construct was produced using the pMSCV retroviral expression system. A pure population of SAR-infected CD34+ stem cells was obtained after cell sorting. Both -and -globin mRNA transcripts were measured dynamically using real-time PCR (Figure 3a, b) . SAR enhanced both -globin and -globin mRNA expression in the CD34+ stem cells, but the effects on -globin were larger and more sustained than the effects on -globin (Figure 3c ). SAR enhanced -globin gene expression 3-fold at day 10, 5.4-fold at day 14, and 15.8-fold at day 18 in SAR-infected CD34+ cells, compared to 5.7-fold at day 10, 1.6-fold at day 14 and 2.9-fold at day18 for -globin mRNA induction.
G1/S phase accumulation and apoptosis in SAR-expressing cells
We also noted that SAR-transfected K562 cells grew more slowly than vector-transfected 
was increased in some of these cells, which also exhibited macrocytic morphology, implying that SAR delayed erythroid maturation. HU-treated K562 cells had similar morphological features, particularly after 4 days of HU treatment (Figure 4b ).
HU not only causes apoptosis in K562 cells, it also upregulates apoptosis-related molecules.
7 As expected, the incidence of apoptosis was notably higher in SAR- 
Increased protein levels of GATA-2 and p21 in SAR-expressing K562 cells
The erythroid transcription factors GATA-1 and GATA-2 are considered to be active modulators of -globin gene expression. 7, 8 We therefore investigated the GATA-1 and
GATA-2 proteins in SAR-expressing K562 cells with Western blots. GATA-2 protein
levels, but not GATA-1, were significantly elevated in these cells compared to vector controls (p < 0.05; Figure 5a ). In the same experiment, similar effects on GATA-1 and GATA-2 protein levels were observed in K562 cells after 3 day of HU treatment.
Interestingly, p21 mRNA was also elevated 2.4-fold in SAR-expressing cells compared to the vector control (Figure 5b ).
Decreased ERK phosphorylation and PI3 kinase accompanied SAR over-expression
Because there was observable growth inhibition in SAR-expressing cells, overexpressing SAR may impact growth-related signals. It has been reported that the inhibition of Ras/ERK enhances erythroid cell differentiation.
27 Therefore, we examined mitogen-and stress-activated signaling molecules in the SAR-expressing cells and vector controls.
Interestingly, phospho-ERK (pERK) levels, but not total ERK protein, decreased in all three SAR-transfected clones compared with vector-transfected cells (Figure 5c ). In contrast, neither the phosphorylation state nor the total level of p38 protein was altered in response to SAR expression (data not shown). ERK phosphorylation transiently decreased after 3 h exposure to 100 µM HU in K562 cells, but returned to baseline by 24h. By using a PowerBlot screen, we also found that the most significant protein change was an 11-fold reduction of PI3 kinase in SAR-expressing clones as compared to vector controls. This result was further confirmed by Western blot (Figure 5d ). SAR has long been known to participate in protein trafficking from the ER to the Golgi complex. 16, 17 The localization of SAR in the endoplasmic reticulum and its association with -globin gene expression demonstrated in this study suggest that SAR may also play a special role in hemoglobin regulation. Although the precise pathway(s) and molecules through which SAR regulates the -globin gene remain unknown, SAR may increase the transport of membrane-bound transcription factor precursors from the endoplasmic reticulum to the Golgi. In this model, the proteolytic cleavage of the precursor proteins in Stable transfection of SAR into K562 cells arrested the cells at a prematurel stage, which is associated with increased synthesis of -globin. K562 cells express -, -, and -globin but not -globin, and HU is reported to promote both -and -globin production. 7, 30 We therefore transduced the SAR gene into CD34+ cells using a retroviral system to investigate its effects on -and -globin production. We found that SAR and HU were similarly able to regulate hemoglobin production in the CD34+ stem cells, and SAR induced both -and -globin production. SAR-mediated -globin induction was more GATA-2 levels increase -globin and -globin transcripts in K562 cells. 8 In the present study, GATA-2 protein levels increased significantly in SAR expressing cells without a significant change in GATA-1, consistent with the effect of HU on parental K562 cells.
We posit that SAR may disturb erythroid maturation by upregulating GATA-2, resulting in an increase in -globin production.
p21 plays a regulatory role within the G 1 /S cell cycle checkpoint. Forced GATA-2 expression inhibits cytokine-dependent growth of normal hematopoietic stem/progenitor shown to inhibit cell growth and gene transcription. 40 ERK activity can be elevated in response to proliferative factors, as well as in response to differentiating agents; related signal molecules can show differences depending on the genetic makeup of cells used in each experiment. ERK dephosphorylation might induce hemoglobin synthesis and inhibit cell proliferation. Therefore, our data suggest that HU-induced increases in -globin gene mRNA levels may involve the PI3 kinase-ERK signal transduction pathway.
For This study represents the first evidence that the small GTP-binding protein SAR participates in cell cycle control through upregulation of GATA-2 and p21 in erythroid maturation, as depicted in Figure 6 . Elucidation of the relationship among SAR's vesicular trafficking functions and -globin induction may allow new therapies for sicklecell disease and -thalassemia. Further studies will determine whether SAR is an obligatory mediator of these effects and will explore the specific molecular pathways involved. Direct interactions between SAR and associated binding partner(s) should be established to provide the molecular basis of SAR function in hemoglobin protein production.
For SAR-expressing cells were arrested in G1/S-phase and showed a decreased G 2 M fraction.
Cell cycle analysis was performed after cells were plated for 48h.
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